• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Medicus Pharma Ltd. - Common Stock (NQ:MDCX)

    0.4420 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,448
    Open 0.4420
    Bid (Size) 0.4403 (1,700)
    Ask (Size) 0.4485 (200)
    Prev. Close 0.4420
    Today's Range 0.4420 - 0.4420
    52wk Range 0.3700 - 8.940
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
    Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development for Near-Term Value Creation, Addressing a $2 Billion Potential Target Market 
    From Medicus Pharma Ltd
    Via GlobeNewswire

    Performance

    YTD
    -72.4%
    -72.4%
    1 Month
    -12.2%
    -12.2%
    3 Month
    -71.7%
    -71.7%
    6 Month
    -82.4%
    -82.4%
    1 Year
    -88.3%
    -88.3%

    More News

    Read More
    News headline image
    Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
    From Medicus Pharma Ltd
    Via GlobeNewswire
    Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026
    Via AB Newswire
    News headline image
    Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
    Via ACCESS Newswire
    News headline image
    Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
    Via ACCESS Newswire
    News headline image
    Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST
    Via ACCESS Newswire
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
    Via ACCESS Newswire
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    News headline image
    American Lithium Minerals (OTC: AMLM) Targets Tokenized Commodities Opportunity Alongside MDCX, ASNS, EONR, ELPW Today!
    Via AB Newswire
    Topics Artificial Intelligence
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
    Via ACCESS Newswire
    Here are the top movers in Friday's session. ↗
    Via Chartmill
    Which stocks are moving on Friday? ↗
    Via Chartmill
    The market is filled with gapping stocks in Friday's session. ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Thursday's session. ↗
    Via Chartmill
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Medicus Pharma Reports Positive Phase 2 SKNJCT-003 Topline Data Observing 73% Clinical Clearance and 40% Histological Clearance (CR) at Day 57 in 200μg Cohort
    From Medicus Pharma Ltd
    Via GlobeNewswire
    News headline image
    Medicus Pharma To Participate in the 38th Annual Roth Conference
    From Medicus Pharma Ltd
    Via GlobeNewswire

    Frequently Asked Questions

    Is Medicus Pharma Ltd. - Common Stock publicly traded?
    Yes, Medicus Pharma Ltd. - Common Stock is publicly traded.
    What exchange does Medicus Pharma Ltd. - Common Stock trade on?
    Medicus Pharma Ltd. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Medicus Pharma Ltd. - Common Stock?
    The ticker symbol for Medicus Pharma Ltd. - Common Stock is MDCX on the Nasdaq Stock Market
    What is the current price of Medicus Pharma Ltd. - Common Stock?
    The current price of Medicus Pharma Ltd. - Common Stock is 0.4420
    When was Medicus Pharma Ltd. - Common Stock last traded?
    The last trade of Medicus Pharma Ltd. - Common Stock was at 04/09/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.